1448317-15-4Relevant articles and documents
A novel five-lipoxygenase activity protein inhibitor labeled with carbon-14 and deuterium
Latli, Bachir,Hrapchak, Matt,Gao, Joe J.,Busacca, Carl A.,Senanayake, Chris H.
, p. 390 - 394 (2015/08/06)
2-[4-(3-{(1R)-1-[4-(2-Aminopyrimidin-5-yl)phenyl]-1-cyclopropylethyl}-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl]-N,N-dimethylacetamide (1), is a novel and selective five-lipoxygenase activity protein (FLAP) inhibitor with excellent pharmacokinetics properties